Status:

RECRUITING

Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection

Lead Sponsor:

University Health Network, Toronto

Collaborating Sponsors:

Ontario Institute for Cancer Research

The Princess Margaret Cancer Foundation

Conditions:

Non Small Cell Lung Cancer

Eligibility:

All Genders

18+ years

Brief Summary

ctDNALung-Detect is an investigator-initiated single arm, multi-institution study designed to assess the ctDNA detection rate and its association with Relapse Free Survival (RFS) in operable stage T1-...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years;
  • Ability to provide written informed consent;
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1;
  • T1-T4 (T3,T4 multifocal) N0M0 NSCLC who are planned for complete surgical resection;
  • Tumour size must be at least 1 cm (unidimensional) and have at least some solid component on imaging;
  • Surgical tumour formalin-fixed, paraffin-embedded (FFPE) specimens for ctDNA studies are required.

Exclusion

  • Prior radiation, surgery or chemotherapy for the current diagnosis of NSCLC is not permitted.
  • Incomplete surgical resection. Participants who had pre-operative ctDNA samples taken but subsequently do not have a complete surgical resection would not qualify for post-operative ctDNA testing.
  • Concurrent enrolment in a therapeutic study using drug or radiation therapy. Enrolment in observational, diagnostic or studies of novel surgical techniques will be allowed.
  • Concurrent active malignancy or other invasive malignancy within previous 2 years. Non-invasive malignancies (i.e., cervical carcinoma in situ, in situ prostate cancer, non-melanomatous carcinoma of the skin, ductal carcinoma in situ of the breast that has been surgically cured) are excluded from this definition.
  • Pregnancy.

Key Trial Info

Start Date :

July 6 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 30 2027

Estimated Enrollment :

360 Patients enrolled

Trial Details

Trial ID

NCT05254782

Start Date

July 6 2021

End Date

March 30 2027

Last Update

December 6 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Michael Garron Hospital

Toronto, Ontario, Canada

2

St. Joseph's Health Centre

Toronto, Ontario, Canada

3

University Health Network

Toronto, Ontario, Canada